Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q2 2021 · 10-Q
Revenue$9.27B$9.27B+34.1% vs Q2 2020 Net Income$1.83B$1.83Bno prior Q2 2020 on file EPS Diluted$4.61$4.61+59.0% vs Q2 2020 Operating Income$2,163,000,000+55.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,687,000,000+4.3% Margins · derivedOperating margin23.3%+3.2 pt vs Q2 2020
Net margin19.7%
ended Jul 3, 2021 · filed Aug 6, 2021 · 34 d after period end